The phenomenon of tumor promoting (oncogenic) activity of the MMP2 was previously demonstrated in colorectal cancer, where elevated MMP2 mRNA levels in “healthy” tissue surrounding the lesion were significantly higher in patients with metastatic cancer than in non-metastatic lesions (46). Here, MMP2 is linked to metastatic malignant neoplasm.